Home
Back to Manufacturing guides

Manufacturing guides

Turnkey Supplement Manufacturing Is Not a Transfer

Turnkey looks like handing over a brief and receiving pallets. Three obligations stay where they are: the facility registration, the name on the label, and the mould. A contract can transfer work; it cannot transfer a licence or the responsibility a regulation attaches to the party named on the pack.

A brand hands over a brief and expects pallets, six months later, on a dock it never visits. That is what turnkey sounds like. What actually arrives is a product, a set of documents, and three obligations that stayed where they were: the registration of the site, the name on the label, and the mould.

None of those is a trick. They are the difference between buying production and buying a business.

A finished, labelled jar in the house pack format, clear PET with a white cap and a navy brand band.
A finished, labelled jar in the house pack format, clear PET with a white cap and a navy brand band.

What the word covers

Turnkey supplement manufacturing usually means one contract covering development, material sourcing, production, packing, testing and the release documentation, with a single point of contact and a single invoice.

That is a real convenience and it is worth paying for. A brand that assembles the same chain itself will place four purchase orders, chase three schedules and reconcile two sets of test results before the first pallet moves.

What turnkey does not change is where the legal obligations sit. A contract can transfer work. It cannot transfer a licence, a registration, or the responsibility that a regulation attaches to the party named on the pack.

The site registration stays with the site

A manufacturing facility is registered, inspected and audited as a facility. That registration belongs to the entity that operates it, and it stays there regardless of whose brand is on the batch.

In the United States, a dietary supplement contract manufacturer that processes, packs or holds product registers its facility with FDA under 21 CFR Part 1, and the preventive controls requirements of 21 CFR 117 apply to that facility for those operations. In the European Union, the site operates under food hygiene rules and the operator's own HACCP-based system; there is no supplement-specific GMP regulation, so a supplier quoting "pharma GMP" is describing a regime your product will not be judged against.

The practical consequence is simple. If a buyer asks for the manufacturing site, the answer is a real address with a real registration behind it, and it does not become the brand's site because the brand paid for the batch. What the brand can ask for is the documentation that shows the site is in good standing, and the audit rights that let it verify.

The name on the label does not move

This is the obligation that surprises first-time buyers most.

In the EU, Regulation (EC) No 178/2002 places responsibility for a food on the food business operator under whose name it is marketed. That is the brand. The manufacturer can appear elsewhere on the pack, and the brand remains the party a member state authority will contact.

In the United States, a dietary supplement does not need premarket approval, but a new dietary ingredient needs a notification filed at least 75 days before marketing, and the party responsible for that notification is the one marketing the product. A contract manufacturer can prepare the file; it cannot become the notifier unless it is also the marketer.

So the turnkey price buys the work of compliance, not the liability of it. That distinction belongs in the contract in plain words, because it is the clause people read after an incident rather than before.

Tooling is an asset, not a service

Gummy moulds, tablet punches and dies, and custom blister cavities are physical assets with a lead time and a scrap value. Who owns them decides what happens when the relationship ends.

A starch mould for a shaped gummy is specific to that shape. If the plant owns it, moving the product means paying for a new mould and waiting for it to be made, which is a practical lock-in even when the contract says the brand is free to leave. If the brand owns it, the contract needs to say where it is stored, who maintains it, what condition it must be returned in, and whether the plant may use it for anyone else.

There is a middle arrangement that is common and should be read carefully: the plant pays for the tooling and amortises it into the unit price. That is fine commercially, and it means the tooling is the plant's until the amortisation is complete or bought out. A brand that assumes otherwise discovers the position at the worst time.

One contact, one failure point

A single point of contact is the main reason brands choose turnkey, and it is also the structural weakness.

When everything is one supplier, a delay in material, a failed assay and a packaging shortage all arrive through the same person, and they all consume the same capacity. There is no second line to shift work to, and no independent test result to compare against.

Two habits reduce that risk without giving up the convenience. The first is a written schedule with named milestones rather than a single delivery date, so a slip is visible at the material stage instead of at the loading bay. The second is a release specification the brand holds independently, so the certificate that arrives at the end is being checked against something other than itself.

Release and its clock

A turnkey project does not end at the last pallet. It ends when the batch is released, and release depends on a sequence that has its own timing.

Typically three batches are made: a pilot or trial batch to confirm the process, and then commercial batches. Stability is started on the first commercial batch, and the pull points run at zero, three, six, twelve and sometimes twenty-four months. The product can ship before those points are read, on a provisional shelf life, and that is normal. What is not normal is discovering at month twelve that the provisional figure was optimistic.

This is where turnkey projects most often look finished and are not. The batch is on a shelf in a warehouse; the evidence behind its shelf life is still being generated. A brand planning a retail launch should treat the stability calendar as part of the critical path, not as paperwork that follows the invoice.

Artwork, versions and who signs

Labels are the part of a turnkey project where the manufacturer's responsibility and the brand's responsibility meet, and the meeting point is an approval.

A workable process has three gates. The brand approves the artwork content, including claims and nutrition figures. The plant checks that what it will print matches the approved file, including version number and any market-specific variant. And a signed proof is retained against the batch record, so that a pallet can be traced to the exact label version it carries.

Without the third gate, a recall becomes an argument about which file was current. With it, the question is answerable in minutes.

What sits outside the turnkey price

Four items are routinely outside, and they are worth listing before the comparison rather than after.

Artwork and prepress, which is a design cost rather than a production cost. Testing beyond the agreed scope, such as an additional marker or a country-specific contaminant panel. Storage beyond an agreed free period, which matters when a launch slips and pallets sit. And freight, duties and import clearance, which belong to whoever is the importer of record.

A quotation that names these four explicitly is easier to compare than one that is silent, because silence gets resolved at the invoice.

The test of a turnkey supplier is not whether it can do everything. It is whether it can tell you, in writing and before you sign, which parts of "everything" remain yours. The scope of the production itself is covered in our note on contract manufacturing, and the difference between full service and a split chain is set out in this comparison.

Ding Shaohua, Foreign Trade Manager at WANHUACAO, works with brands and distributors on supplement programmes from brief to first shipment, in bulk and in private label, across gummies, capsules, powders and tea. The plant operates under SGS CN23/00007035 for gel confectionery and SC11434160205012 covering eight dosage forms, sports nutrition supplements among them. Reach him on WhatsApp, TikTok, LinkedIn and Facebook.

FAQ

Does turnkey mean I do not need my own regulatory work?

It means the manufacturer does the regulatory preparation it is competent to do, which is usually the site documentation, the specifications and the test reports. It does not mean the brand stops being the responsible operator. The name on the pack, the notification or the new dietary ingredient filing, and the import documentation remain with the marketer.

Who owns the moulds for a custom gummy shape?

Whoever paid for them, if the contract says so. The three common arrangements are brand-owned, plant-owned, and plant-owned with amortisation recovered in the unit price. The third is the one most often misunderstood: until the tooling is bought out, leaving means leaving the mould behind.

Can I move production to another plant later?

Legally yes, practically it depends on the technical package. A product that was developed under contract R&D transfers well if the process parameters, specifications and methods were handed over. A product built on a catalogue formula the plant owns does not transfer at all, because there is nothing to hand over. The formulation side is where that is decided.

How long before the first pallet ships?

It depends on whether a new formula is involved. An existing formula with an existing pack can move quickly once materials are in. A new formula needs bench work, a trial batch and artwork, and the stability clock starts after the first commercial batch rather than before it. A supplier that offers a firm date before the formula is fixed is guessing.

All News